
APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract
April 6th, 2022
APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract
April 6th, 2022
Linea 1.0 COVID-19 Assay: Rapid Detection of Omicron Subvariant BA.2
January 28th, 2022
Request for FDA EUA for Linea™ 2.0 COVID-19 Assay, Linea™ Unsupervised At-Home Sample Collection Kit
January 21st, 2022
APDN Announces Continued Momentum in COVID-19 Testing Demand
January 18th, 2022
APDN Receives NYS Dept of Health Conditional Approval for Linea™ 2.0
January 4th, 2022
APDN Strategy to Address Omicron SARS-CoV-2 Variant
November 29th, 2021
APDN & CLEARED4 Offer Solution for OSHA COVID Mandate Compliance
November 5th, 2021
APDN Submits FDA EUA Request for Linea™ SARS-CoV-2 Mutation Panel
October 25th, 2021
APDN Implements safeCircle™ COVID Testing Program at Sarah Lawrence
October 12th, 2021